comparemela.com

Latest Breaking News On - Cell therapy platform combining robotics - Page 1 : comparemela.com

Astellas Announces a Collaboration with YASKAWA to Create an Innovative Cell Therapy Ecosystem through the Integration of Pharmaceutical and Robotics Technologies

- Focuses on digitizing cell manufacturing processes through robotics technology TOKYO, May 21, 2024 /PRNewswire/ Astellas Pharma Inc. today announced that it signed a memorandum of.

Naoki okamuraAstellas pharma incPrnewswire astellas pharma incSafety of products including pharmaceuticalsRobotic biology instituteMedical deviceAstellas pharmaCell therapy platform combining roboticsMedical device actSecuring qualityProducts including pharmaceuticalsFocus area approach

Astellas Announces A Collaboration With YASKAWA To Create An Innovative Cell Therapy Ecosystem Through The Integration Of Pharmaceutical And Robotics

- Focuses on digitizing cell manufacturing processes through robotics technologyTOKYO, May 21, 2024 /PRNewswire/ Astellas Pharma Inc. (

Naoki okamuraRobotic biology institutePrnewswire astellas pharma incAstellas pharma incSafety of products including pharmaceuticalsMedical deviceAstellas pharmaCell therapy platform combining roboticsMedical device actSecuring qualityProducts including pharmaceuticalsFocus area approach

Astellas Announces a Collaboration with YASKAWA to Create an Innovative Cell Therapy Ecosystem through the Integration of Pharmaceutical and Robotics Technologies - Astellas Pharma (OTC:ALPMY)

- Focuses on digitizing cell manufacturing processes through robotics technology TOKYO, May 21, 2024 /PRNewswire/ Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced

Naoki okamuraAstellas pharma incSafety of products including pharmaceuticalsRobotic biology institutePrnewswire astellas pharma incMedical deviceAstellas pharmaCell therapy platform combining roboticsMedical device actSecuring qualityProducts including pharmaceuticalsFocus area approach

vimarsana © 2020. All Rights Reserved.